Kestra Advisory Services, LLC Beyond Air, Inc. Transaction History

Kestra Advisory Services, LLC

  • $17.6 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
SELL
$5.47 - $7.9 $69,195 - $99,935
-12,650 Reduced 50.6%
12,350 $80,000
Q3 2022

Nov 01, 2022
SELL
$7.42 - $11.39 $155,449 - $238,620
-20,950 Reduced 45.59%
25,000 $186 Million
Q2 2022

Aug 12, 2022
BUY
$4.96 - $7.83 $73,160 - $115,492
14,750 Added 47.28%
45,950 $307,000
Q1 2022

Apr 26, 2022
BUY
$6.33 - $9.53 $197,496 - $297,336
31,200 New
31,200 $208,000

Others Institutions Holding XAIR

# of Institutions
64
Shares Held
11.1M
Call Options Held
54.4K
Put Options Held
7K
View Full List

About Beyond Air, Inc.

XAIR Quotes by TradingView
  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email